Table 2 Comparisons of clinical and laboratory parameters in the two groups
| Group 1: Patients with diffuse uptake | Group 2: Patients without diffuse uptake | p | |
|---|---|---|---|
| n (female) | 13 (10) | 5 (3) | 0.583 |
|
Serum TSH Median (minimum-maximum) | 22.43 (3.24–266.1) | 11.01 (0.033–12.27) | 0.143 |
|
Serum TSH (only patients without replacement therapy) Median (minimum-maximum) | 8.45 (3.24–266.1) | 8.20 (0.03–11.23) | 0.414 |
|
Serum free T3 Median (minimum-maximum) | 2.20 (1.16–3.21) | 2.39 (0.89–3.12) | 0.921 |
|
Serum free T4 Median (minimum-maximum) | 0.93 (0.19–1.32) | 1.11 (0.96–1.56) | < 0.05 |
|
Serum free T4 (only patients without replacement therapy) Median (minimum-maximum) | 0.94 (0.19–1.32) | 1.10 (0.96–1.23) | 0.247 |
|
Serum thyroglobulin Median (minimum-maximum) | 1.465 (0.08–175.0) | 3.435 (2.94–3.93) | 0.533 |
|
Tg-Ab titer Median (minimum-maximum) | 1360 (122–4000) | 18 (16–465) | < 0.01 |
|
TPO-Ab titer Median (minimum-maximum) | 184 (16–600) | 16 (8–22) | < 0.01 |